Exposure to antipsychotics and risk of stroke: self controlled case series study
- PMID: 18755769
- PMCID: PMC2526549
- DOI: 10.1136/bmj.a1227
Exposure to antipsychotics and risk of stroke: self controlled case series study
Abstract
Objectives: To investigate the association between use of typical and atypical antipsychotic drugs and incidence of stroke in patients with and without dementia.
Design: Self controlled case series.
Setting: UK based electronic primary care records in the general practice research database (GPRD).
Participants: All patients registered in the database with a recorded incident stroke and at least one prescription for any antipsychotic drug before the end of 2002: 6790 eligible participants were identified and included in the final analysis.
Main outcome measures: Rate ratio for stroke in periods of time exposed to antipsychotics compared with unexposed periods.
Results: Use of any antipsychotic drug was associated with a rate ratio for stroke of 1.73 (95% confidence interval 1.60 to 1.87): 1.69 (1.55 to 1.84) for typical antipsychotics and 2.32 (1.73 to 3.10) for atypical antipsychotics. In patients receiving any antipsychotic drug, the rate ratios were 3.50 (2.97 to 4.12) for those with dementia and 1.41 (1.29 to 1.55) for those without dementia.
Conclusions: All antipsychotics are associated with an increased risk of stroke, and the risk might be higher in patients receiving atypical antipsychotics than those receiving typical antipsychotics. People with dementia seem to be at a higher risk of an associated stroke than people without dementia and use of antipsychotics should, when possible, be avoided in these patients.
Conflict of interest statement
Competing interests: None declared.
Figures

Comment in
-
The self controlled case series method.BMJ. 2008 Aug 28;337:a1069. doi: 10.1136/bmj.a1069. BMJ. 2008. PMID: 18755768 No abstract available.
-
Antipsychotics and stroke risk. Madness of modern medicine.BMJ. 2008 Sep 16;337:a1670. doi: 10.1136/bmj.a1670. BMJ. 2008. PMID: 18796484 No abstract available.
-
Effect of antipsychotics on stroke risk remains unproved.BMJ. 2008 Sep 16;337:a1673. doi: 10.1136/bmj.a1673. BMJ. 2008. PMID: 18796486 No abstract available.
Similar articles
-
Risk of hospitalization for stroke associated with antipsychotic use in the elderly: a self-controlled case series.Drugs Aging. 2010 Nov 1;27(11):885-93. doi: 10.2165/11584490-000000000-00000. Drugs Aging. 2010. PMID: 20964462
-
Risk of cerebrovascular accident associated with use of antipsychotics: population-based case-control study.J Am Geriatr Soc. 2011 Jul;59(7):1182-7. doi: 10.1111/j.1532-5415.2011.03479.x. Epub 2011 Jun 30. J Am Geriatr Soc. 2011. PMID: 21718267
-
Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study.BMJ. 2005 Feb 26;330(7489):445. doi: 10.1136/bmj.38330.470486.8F. Epub 2005 Jan 24. BMJ. 2005. PMID: 15668211 Free PMC article.
-
Using antipsychotic agents in older patients.J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. J Clin Psychiatry. 2004. PMID: 14994733 Review.
-
Do atypical antipsychotics cause stroke?CNS Drugs. 2005;19(2):91-103. doi: 10.2165/00023210-200519020-00001. CNS Drugs. 2005. PMID: 15697324 Review.
Cited by
-
Atrial Fibrillation and Injected Aripiprazole: A Case Report.Innov Clin Neurosci. 2018 Jun 1;15(5-6):43-45. Innov Clin Neurosci. 2018. PMID: 30013819 Free PMC article.
-
Performing studies using the UK Clinical Practice Research Datalink: to link or not to link?Eur J Epidemiol. 2018 Jun;33(6):601-605. doi: 10.1007/s10654-018-0389-5. Epub 2018 Apr 4. Eur J Epidemiol. 2018. PMID: 29619668
-
Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study.BMJ. 2022 Mar 23;376:e066192. doi: 10.1136/bmj-2021-066192. BMJ. 2022. PMID: 35321876 Free PMC article.
-
How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.BMJ Open. 2019 May 14;9(5):e026171. doi: 10.1136/bmjopen-2018-026171. BMJ Open. 2019. PMID: 31092652 Free PMC article.
-
Pharmacological Management of Neuropsychiatric Symptoms of Dementia.Curr Treat Options Psychiatry. 2020 Dec;7(4):489-507. doi: 10.1007/s40501-020-00233-9. Epub 2020 Sep 2. Curr Treat Options Psychiatry. 2020. PMID: 33344107 Free PMC article.
References
-
- Health Canada. Important drug safety information: RISPERDAL* (risperidone) and cerebrovascular adverse events in placebo-controlled dementia trials. Toronto: Janssen-Ortho, 2002. http://hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/2002/risperdal_hp....
-
- Committee on Safety of Medicines. Atypical antipsychotic drugs and stroke: message from Professor Gordon Duff, chairman, (CEM/CMO/2004/1). London: Committee on Safety of Medicines, 2006.
-
- Herrmann N, Mamdani M, Lanctot KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 2004;161:1113-5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical